PREDICTIVE BIOMARKER OF SURVIVAL IN THE TREATMENT OF RENAL CELL CARCINOMA
摘要
Methods and compositions are disclosed for predicting and treating the clinical benefit to a human renal cell carcinoma patient prior to their treatment with a VEGFR inhibitor and an Ang2 inhibitor.
申请公布号
WO2013003606(A1)
申请公布日期
2013.01.03
申请号
WO2012US44673
申请日期
2012.06.28
申请人
AMGEN INC.;ANDERSON, ABRAHAM, ANTONIO;WEINREICH, DAVID, M.
